NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Genital ulcerations (GU) occurring during foscarnet (F) therapy.

Picard C, Salmon D, Fegueux S, Longuet P, Sauvage C, Gilquin J, Desmoulins T; International Conference on AIDS.

Int Conf AIDS. 1990 Jun 20-23; 6: 232 (abstract no. Th.B.440).

Hopital Bichat-Claude Bernard, Paris, France

OBJECTIVE: To describe a new side effect of F observed in AIDS patients (pts). METHODS: Between 1985 and 1989, AIDS pts who developed G.U under F therapy for CMV retinitis, were evaluated with biological, viral, bacteriological and histological investigations. RESULTS: Eleven homosexual men, mean age 38 years, developed erosive, bullous, tender ulcerations of glans penis and cervix glandis, size 1-5 cm, number 2-5. Oral localisations were associated in 4/11. Eight/11 had previous Kaposi sarcoma. Mean duration of AIDS was 16 months (1-37). Viral cultures were negative in 8/8, histology showed inflammatory infiltrate in 3/3, without viral inclusion. Neutrophil count was 1080 mm3 (400-1530), CD4 count 6 mm3 (2-11). Renal function was normal in 11/11. Other treatment included sulfamid 4/11. Lesions appeared in 7/11 during first induction after 16 days (10-27); 2/11 during maintenance therapy after 9 and 178 days; 2/11 during ulterior induction therapy after 11 and 15 days. Treatment was stopped in 7/11 because of pain: healing was obtained in 7/7 after 6 to 12 days. Reintroduction induced relapse in 2/2 after 2 days; there was no healing when treatment was maintained. CONCLUSION: Imputability criteria (delay of occurrence, healing after treatment interruption, relapse with reintroduction, absence of other etiology) suggest that G.U are a F. related eruption. Frequency of this previously undescribed side-effect of F. has to be estimated prospectively.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Acquired Immunodeficiency Syndrome
  • CD4 Lymphocyte Count
  • Cytomegalovirus Retinitis
  • Drug Therapy, Combination
  • Female
  • Female Urogenital Diseases
  • Foscarnet
  • Humans
  • Male
  • drug therapy
  • therapy
Other ID:
  • 10044090
UI: 102182017

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov